Toll-like Receptor (TLR) 3 Immune Modulation by Unformulated Small Interfering RNA or DNA and the Role of CD14 (in TLR-mediated Effects)

Overview

Journal Immunology

Specialty Allergy & Immunology

Date 2012 Jan 21

PMID 22260507

Citations 32

Authors

Cordula Weber

Christian Muller

Anja Podszuweit

Carmen Montino

Jorg Vollmer

Alexandra Forsbach

Affiliations

Soon will be listed here.

Abstract

The Toll-like receptors (TLRs) 3, 7, 8 and 9 stimulate innate immune responses upon recognizing pathogen-derived nucleic acids. TLR3 is located on the cell surface and in cellular endosomes and recognizes double-stranded viral RNA or the synthetic mimic poly rI:rC. Recently, unformulated small interfering RNA (siRNA) has been reported as ligand for surface-expressed murine TLR3. Blockage of TLR3 is achieved by single-stranded DNA. We confirm and expand the observation that poly rI:rC-mediated TLR3 immune activation is blocked in a sequence-, length-, backbone- and CpG-dependent manner. However, human TLR3 is not activated by siRNA, which may be the result of differences in the amino acid composition of the TLR3 loop 1 of mice and humans. Although CD14 was previously described as a co-receptor for murine TLR3 and other nucleic acid-recognizing TLRs, human CD14 acts only as co-receptor to human TLR9, but not TLR3, TLR7 or TLR8. We show that CD14 up-regulates the TLR9 immune response of A, B and C-class oligodeoxynucleotides but down-regulates the phosphoro-diester version of B-class oligodeoxynucleotides.

Citing Articles

Erythrocytes of the common carp are immune sentinels that sense pathogen molecular patterns, engulf particles and secrete pro-inflammatory cytokines against bacterial infection.

Majstorovic J, Kyslik J, Klak K, Maciuszek M, Chan J, Korytar T Front Immunol. 2024; 15:1407237.

PMID: 38947329 PMC: 11211254. DOI: 10.3389/fimmu.2024.1407237.

Hypermethylated genome of a fish vertebrate iridovirus ISKNV plays important roles in viral infection.

Liang M, Pan W, You Y, Qin X, Su H, Zhan Z Commun Biol. 2024; 7(1):237.

PMID: 38413759 PMC: 10899263. DOI: 10.1038/s42003-024-05919-x.

Short chain fatty acids inhibit corneal inflammatory responses to TLR ligands via the ocular G-protein coupled receptor 43.

Wu J, Chen N, Grau E, Johnson L, Liu Y, Li C Ocul Surf. 2024; 32:48-57.

PMID: 38224777 PMC: 11056309. DOI: 10.1016/j.jtos.2024.01.005.

Inhibition of Toll-like receptor 4 and Interleukin-1 receptor prevent SARS-CoV-2 mediated kidney injury.

Nakazawa D, Takeda Y, Kanda M, Tomaru U, Ogawa H, Kudo T Cell Death Discov. 2023; 9(1):293.

PMID: 37563112 PMC: 10415265. DOI: 10.1038/s41420-023-01584-x.

TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for targeting cancers: discovery process and biological characterization.

Thierry S, Maadadi S, Berton A, Dimier L, Perret C, Vey N Microb Cell. 2023; 10(6):117-132.

PMID: 37275475 PMC: 10236204. DOI: 10.15698/mic2023.06.797.

References

Jurk M, Kritzler A, Debelak H, Vollmer J, Krieg A, Uhlmann E . Structure-activity relationship studies on the immune stimulatory effects of base-modified CpG toll-like receptor 9 agonists. ChemMedChem. 2006; 1(9):1007-14. DOI: 10.1002/cmdc.200600064. View

Kleinman M, Yamada K, Takeda A, Chandrasekaran V, Nozaki M, Baffi J . Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature. 2008; 452(7187):591-7. PMC: 2642938. DOI: 10.1038/nature06765. View

Krug A, Rothenfusser S, Hornung V, Jahrsdorfer B, Blackwell S, Ballas Z . Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol. 2001; 31(7):2154-63. DOI: 10.1002/1521-4141(200107)31:7<2154::aid-immu2154>3.0.co;2-u. View

Okahira S, Nishikawa F, Nishikawa S, Akazawa T, Seya T, Matsumoto M . Interferon-beta induction through toll-like receptor 3 depends on double-stranded RNA structure. DNA Cell Biol. 2005; 24(10):614-23. DOI: 10.1089/dna.2005.24.614. View

Puig M, Grajkowski A, Boczkowska M, Ausin C, Beaucage S, Verthelyi D . Use of thermolytic protective groups to prevent G-tetrad formation in CpG ODN type D: structural studies and immunomodulatory activity in primates. Nucleic Acids Res. 2006; 34(22):6488-95. PMC: 1702498. DOI: 10.1093/nar/gkl867. View

Zelphati O, Szoka Jr F . Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids. Pharm Res. 1996; 13(9):1367-72. DOI: 10.1023/a:1016026101195. View

Barton G, Kagan J, Medzhitov R . Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol. 2005; 7(1):49-56. DOI: 10.1038/ni1280. View

Baumann C, Aspalter I, Sharif O, Pichlmair A, Bluml S, Grebien F . CD14 is a coreceptor of Toll-like receptors 7 and 9. J Exp Med. 2010; 207(12):2689-701. PMC: 2989773. DOI: 10.1084/jem.20101111. View

Berge M, Bonnin P, Sulpice E, Vilar J, Allanic D, Silvestre J . Small interfering RNAs induce target-independent inhibition of tumor growth and vasculature remodeling in a mouse model of hepatocellular carcinoma. Am J Pathol. 2010; 177(6):3192-201. PMC: 2993283. DOI: 10.2353/ajpath.2010.100157. View

10.

Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S . Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 2004; 303(5663):1526-9. DOI: 10.1126/science.1093620. View

11.

Nishiya T, Kajita E, Miwa S, DeFranco A . TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements. J Biol Chem. 2005; 280(44):37107-17. DOI: 10.1074/jbc.M504951200. View

12.

Cho W, Albuquerque R, Kleinman M, Tarallo V, Greco A, Nozaki M . Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth. Proc Natl Acad Sci U S A. 2009; 106(17):7137-42. PMC: 2678451. DOI: 10.1073/pnas.0812317106. View

13.

Marques J, Devosse T, Wang D, Zamanian-Daryoush M, Serbinowski P, Hartmann R . A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat Biotechnol. 2006; 24(5):559-65. DOI: 10.1038/nbt1205. View

14.

Marshall J, Fearon K, Abbate C, Subramanian S, Yee P, Gregorio J . Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions. J Leukoc Biol. 2003; 73(6):781-92. DOI: 10.1189/jlb.1202630. View

15.

Gowen B, Wong M, Jung K, Sanders A, Mitchell W, Alexopoulou L . TLR3 is essential for the induction of protective immunity against Punta Toro Virus infection by the double-stranded RNA (dsRNA), poly(I:C12U), but not Poly(I:C): differential recognition of synthetic dsRNA molecules. J Immunol. 2007; 178(8):5200-8. DOI: 10.4049/jimmunol.178.8.5200. View

16.

Latz E, Visintin A, Lien E, Fitzgerald K, Monks B, Kurt-Jones E . Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J Biol Chem. 2002; 277(49):47834-43. DOI: 10.1074/jbc.M207873200. View

17.

Bell J, Mullen G, Leifer C, Mazzoni A, Davies D, Segal D . Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol. 2003; 24(10):528-33. DOI: 10.1016/s1471-4906(03)00242-4. View

18.

Akashi-Takamura S, Miyake K . TLR accessory molecules. Curr Opin Immunol. 2008; 20(4):420-5. DOI: 10.1016/j.coi.2008.07.001. View

19.

Elbashir S, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T . Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001; 411(6836):494-8. DOI: 10.1038/35078107. View

20.

Kariko K, Ni H, Capodici J, Lamphier M, Weissman D . mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem. 2004; 279(13):12542-50. DOI: 10.1074/jbc.M310175200. View